The Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer
Author:
Publisher
Elsevier BV
Subject
Urology
Reference304 articles.
1. New strategies in bladder cancer: a second coming for immunotherapy;Ghasemzadeh;Clin Cancer Res,2016
2. Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches;Song;J Pathol,2019
3. Immunotherapy in Bladder Cancer: Current Methods and Future Perspectives;Wolacewicz;Cancers (Basel),2020
4. The Tumor Immune Contexture of Prostate Cancer;Vitkin;Front Immunol,2019
5. Immunotherapy of Prostate Cancer: Facts and Hopes;Bilusic;Clin Cancer Res,2017
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Activation of Stimulator of Interferon Genes (STING): Promising Strategy to Overcome Immune Resistance in Prostate Cancer;Current Medicinal Chemistry;2024-12
2. Data-mining-based biomarker evaluation and experimental validation of SHTN1 for bladder cancer;Cancer Genetics;2024-11
3. Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer;Cancer Cell International;2024-08-17
4. From foes to friends: rethinking the role of lymph nodes in prostate cancer;Nature Reviews Urology;2024-08-02
5. The reactive stroma response regulates the immune landscape in prostate cancer;Journal of Translational Genetics and Genomics;2024-07-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3